Trachoma Surveys 2000-2005: Results, Recent Advances in Methodology, and Factors Affecting the Determination of Prevalence

Survey of Ophthalmology

Volumn 52, Issue 5, 2007, Pages 535-546

  Lansingh, Van C ^a   Carter, Marissa J ^b  

^a FUNDACIÓN VISIÓN   (Paraguay)

^b Strategic Solutions Inc   (United States)

Author keywords

clinical assessment; PCR; prevalence; survey; TRA; trachoma

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; EYE DISEASE; HEALTH SURVEY; HUMAN; LABORATORY TEST; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; TRACHOMA;

EPIDEMIOLOGIC METHODS; HEALTH SURVEYS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; TRACHOMA; WORLD HEALTH;

EID: 34547960527     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2007.06.007     Document Type: Article

References (72)

1. al Arab G.E., Tawfik N., El Gendy R., et al. The burden of trachoma in the rural Nile Delta of Egypt: a survey of Menofiya governorate. Br J Ophthalmol 85 (2001) 1406-1410
2. Alene G.D., and Abebe S. Prevalence of risk factors for trachoma in a rural locality of north-western Ethiopia. East Afr Med J 77 (2000) 308-312
3. Alves A.P., Medina N.H., and Cruz A.A. Trachoma and ethnic diversity in the Upper Rio Negro Basin of Amazonas State, Brazil. Ophthalmic Epidemiol 9 (2002) 29-34
4. Assefa T., Argaw D., Foster A., et al. Results of trachoma rapid assessment in 11 villages of South Gonder zone, Ethiopia. Trop Doct 31 (2001) 202-204
5. Babalola O.E., Abiose A., and Barrie J.R. The problem of trachoma within an onchocerciasis-endemic zone in Kaduna: need for a multilateral approach?. Ophthalmic Epidemiol 12 (2005) 311-319
6. Bailey R., Duong T., Carpenter R., et al. The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect 123 (1999) 479-486
7. Bailey R., Osmond C., Mabey D.C., et al. Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure. Int J Epidemiol 18 (1989) 944-951
8. Baral K., Osaki S., Shreshta B., et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull World Health Organ 77 (1999) 461-466
9. Bejiga A., and Alemayehu W. Prevalence of trachoma and its determinants in Dalocha District, Central Ethiopia. Ophthalmic Epidemiol 8 (2001) 119-125
10. Bird M., Dawson C.R., Schachter J.S., et al. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?. J Infect Dis 187 (2003) 1669-1673
11. Bowman R.J., Sillah A., Van Dehn C., et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci 41 (2000) 4074-4079
12. Burton M.J., Bailey R.L., Jeffries D., et al. Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun 72 (2004) 7352-7356
13. Burton M.J., Holland M.J., Faal N., et al. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci 44 (2003) 4215-4222
14. Burton M.J., Holland M.J., Makalo P., et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 365 (2005) 1321-1328
15. Courtright P., and West S.K. Contribution of sex-linked biology and gender roles to disparities with trachoma. Emerg Infect Dis 10 (2004) 2012-2016
16. Cumberland P., Hailu G., and Todd J. Active trachoma in children aged three to nine years in rural communities in Ethiopia: prevalence, indicators and risk factors. Trans R Soc Trop Med Hyg 99 (2005) 120-127
17. da Cruz L., Dadour I.R., McAllister I.L., et al. Seasonal variation in trachoma and bush flies in north-western Australian Aboriginal communities. Clin Experiment Ophthalmol 30 (2002) 80-83
18. Diamant J., Benis R., Schachter J., et al. Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic Epidemiol 8 (2001) 109-117
19. Dolin P.J., Faal H., Johnson G.J., et al. Trachoma in The Gambia. Br J Ophthalmol 82 (1998) 930-933
20. Dunzhu S., Wang F.S., Courtright P., et al. Blindness and eye diseases in Tibet: findings from a randomised, population based survey. Br J Ophthalmol 87 (2003) 1443-1448
21. Emerson P.M., Lindsay S.W., Alexander N., et al. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet 363 (2004) 1093-1098
22. Ewald D.P., Hall G.V., and Franks C.C. An evaluation of a SAFE-style trachoma control program in Central Australia. Med J Aust 178 (2003) 65-68
23. Frick K.D., Lietman T.M., Holm S.O., et al. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bull World Health Organ 79 (2001) 201-207
24. Gaynor B.D., Miao Y., Cevallos V., et al. Eliminating trachoma in areas with limited disease. Emerg Infect Dis 9 (2003) 596-598
25. Hessel T., Dhital S.P., Plank R., et al. Immune response to chlamydial 60-kilodalton heat shock protein in tears from Nepali trachoma patients. Infect Immun 69 (2001) 4996-5000
26. Hoechsmann A., Metcalfe N., Kanjaloti S., et al. Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophthalmic Epidemiol 8 (2001) 145-153
27. Holm S.O., Jha H.C., Bhatta R.C., et al. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bull World Health Organ 79 (2001) 194-200
28. Hsieh Y.H., Bobo L.D., Quinn T.C., et al. Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years. Am J Epidemiol 152 (2000) 204-211
29. Javaloy J., Ferrer C., Vidal M.T., et al. Follicular conjunctivitis caused by Chlamydia trachomatis in an infant Saharan population: molecular and clinical diagnosis. Br J Ophthalmol 87 (2003) 142-146
30. Jha H., Chaudary J.S., Bhatta R., et al. Disappearance of trachoma from Western Nepal. Clin Infect Dis 35 (2002) 765-768
31. Katz J., Zeger S.L., and Tielsch J.M. Village and household clustering of xerophthalmia and trachoma. Int J Epidemiol 17 (1988) 865-869
32. Koizumi I.K., Medina N.H., D'Amaral R.K.K., et al. Prevalence of trachoma in preschool and schoolchildren in the city of Sao Paulo. Rev Saude Publica 39 (2005) 937-942
33. Kuper H., Solomon A.W., Buchan J.C., et al. Participatory evaluations of trachoma control programmes in eight countries. Trop Med Int Health 10 (2005) 764-772
34. Laming A.C., Currie B.J., DiFrancesco M., et al. A targeted, single-dose azithromycin strategy for trachoma. Med J Aust 172 (2000) 163-166
35. Laming AC, Currie BJ: An evaluation of a SAFE-style trachoma control program in central Australia. Med J Aust 179:117, author reply 117-8, 2003
36. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
37. Lansingh V.C., Weih L.M., Keeffe J.E., et al. Assessment of trachoma prevalence in a mobile population in Central Australia. Ophthalmic Epidemiol 8 (2001) 97-108
38. Limburg H., Bah M., and Johnson G.J. Trial of the Trachoma Rapid Assessment methodology in The Gambia. Ophthalmic Epidemiol 8 (2001) 73-85
39. Liu H., Ou B., Paxton A., et al. Rapid assessment of trachoma in Hainan Province, China: validation of the new World Health Organization methodology. Ophthalmic Epidemiol 9 (2002) 97-104
40. Madani M.O., Huguet P., Mariotti S.P., et al. [Trachoma in Chad: results of an epidemiological survey]. Sante 13 (2003) 9-15
41. Mariotti S.P., Pararajasegaram R., and Resnikoff S. Trachoma: looking forward to Global Elimination of Trachoma by 2020 (GET 2020). Am J Trop Med Hyg 69 (2003) 33-35
42. Medina N.H., Gattas V.L., Anjos G.L., et al. [Trachoma prevalence in preschoolers and schoolchildren in Botucatu, São Paulo State, Brazil, 1992]. Cad Saude Publica 18 (2002) 1537-1542
43. Melese M., Chidambaram J.D., Alemayehu W., et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 292 (2004) 721-725
44. Miller K., Schmidt G., Melese M., et al. How reliable is the clinical exam in detecting ocular chlamydial infection?. Ophthalmic Epidemiol 11 (2004) 255-262
45. Moalic E., Dueymes J.M., Baron R., et al. Cross-sectional survey of trachoma in school age children in the region of Thiès (Senegal). Pediatr Infect Dis J 19 (2000) 979-983
46. Myatt M., Limburg H., Minassian D., et al. Field trial of applicability of lot quality assurance sampling survey method for rapid assessment of prevalence of active trachoma. Bull World Health Organ 81 (2003) 877-885
47. Paterson B., et al. Trachoma: new problem or old dilemma. Northern Territory Dis Control Bull 9 (2002) 1-5
48. Paula J.S., Medina N.H., and Cruz A.A. Trachoma among the Yanomami Indians. Braz J Med Biol Res 35 (2002) 1153-1157
49. Paxton A. Rapid assessment of trachoma prevalence-Singida, Tanzania. A study to compare assessment methods. Ophthalmic Epidemiol 8 (2001) 87-96
50. Pizzarello L., Abiose A., Ffytche T., et al. VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness. Arch Ophthalmol 122 (2004) 615-620
51. Polack S.R., Solomon A.W., Alexander N.D., et al. The household distribution of trachoma in a Tanzanian village: an application of GIS to the study of trachoma. Trans R Soc Trop Med Hyg 99 (2005) 218-225
52. Rabiu M.M., Alhassan M.B., and Abiose A. Trial of Trachoma Rapid Assessment in a subdistrict of northern Nigeria. Ophthalmic Epidemiol 8 (2001) 263-272
53. Regassa K., and Teshome T. Trachoma among adults in Damot Gale District, South Ethiopia. Ophthalmic Epidemiol 11 (2004) 9-16
54. Reinhards J., Weber A., Nizetic B., et al. Studies in the epidemiology and control of seasonal conjunctivitis and trachoma in southern Morocco. Bull World Health Organ 39 (1968) 497-545
55. Resnikoff S., Pascolini D., Etya'ale D., et al. Global data on visual impairment in the year 2002. Bull World Health Organ 82 (2004) 844-851
56. Saal M.B., Schemann J.F., Saar B., et al. [Trachoma in Senegal: results of a national survey]. Med Trop (Mars) 63 (2003) 53-59
57. Schémann J.F., Banou A.A., and Sacko D. [Rapid trachoma assessment method (TRA): comparison with an exhaustive prevalence survey in a region of endemic trachoma in Mali]. Sante 10 (2000) 59-64
58. Schémann J.F., Sacko D., Malvy D., et al. Risk factors for trachoma in Mali. Int J Epidemiol 31 (2002) 194-201
59. Solomon A.W., Holland M.J., Alexander N.D., et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 351 (2004) 1962-1971
60. Solomon A.W., Holland M.J., Burton M.J., et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 362 (2003) 198-204
61. Solomon A.W., Peeling R.W., Foster A., et al. Diagnosis and assessment of trachoma. Clin Microbiol Rev 17 (2004) 982-1011
62. Taylor H.R. Trachoma grading: a new grading scheme. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique (1987) 175-181
63. Thein J., Zhao P., Liu H., et al. Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?. Ophthalmic Epidemiol 9 (2002) 263-269
64. Thylefors B., Dawson C.R., Jones B.R., et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65 (1987) 477-483
65. Thylefors B., Négrel A.D., Pararajasegaram R., et al. Global data on blindness. Bull World Health Organ 73 (1995) 115-121
66. Wedner S.H., Ross D.A., Balira R., et al. Prevalence of eye diseases in primary school children in a rural area of Tanzania. Br J Ophthalmol 84 (2000) 1291-1297
67. West E.S., Munoz B., Mkocha H., et al. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci 46 (2005) 83-87
68. West S.K., Munoz B., Mkocha H., et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366 (2005) 1296-1300
69. West S.K. Trachoma: new assault on an ancient disease. Prog Retin Eye Res 23 (2004) 381-401
70. Wright H.R., and Taylor H.R. Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?. Lancet Infect Dis 5 (2005) 313-320
71. Wright H.R., Vu H., and Taylor H.R. How to assess the prevalence of trachoma. Br J Ophthalmol 89 (2005) 526-527
72. Zeger S.L., Liang K.Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988) 1049-1060